
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (8) Apply Advertising filter
- Advisory bodies/Committees (1) Apply Advisory bodies/Committees filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (9) Apply Biologicals filter
- Blood and blood components (4) Apply Blood and blood components filter
- Complementary medicines (23) Apply Complementary medicines filter
- Cosmetics (2) Apply Cosmetics filter
- Disinfectants/Sterilants (4) Apply Disinfectants/Sterilants filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (23) Apply Labelling/Packaging filter
- Legislation (20) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (12) Apply Manufacturing filter
- Medical devices safety (1) Apply Medical devices safety filter
- Medical devices/IVDs (49) Apply Medical devices/IVDs filter
- Medicinal cannabis (2) Apply Medicinal cannabis filter
- Medicines (1) Apply Medicines filter
- OTC medicines (33) Apply OTC medicines filter
- Prescription medicines (26) Apply Prescription medicines filter
- Safety of medicines & medical devices (2) Apply Safety of medicines & medical devices filter
- Scheduling (67) Apply Scheduling filter
- Sunscreens (1) Apply Sunscreens filter
- Therapeutic Goods Administration (TGA) (9) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (6) Apply Therapeutic goods regulation filter
Proposal to remove redundant processes for entering certain formulation information into a therapeutic goods application
Closes on 24 February 2021
Australian Regulations definition of Central Circulatory System (CCS)
Closes on 10 February 2021
Potential reforms to medicinal cannabis manufacturing, labelling and packing requirement
Closes on 29 January 2021
Proposed amendments to the Poisons Standard - ACMS, ACCS and Joint ACMS/ACCS meetings, March 2021
Closes on 27 January 2021
Compounded medicines and good manufacturing practice (GMP)
Closed on 18 December 2020
IMDRF consultation: Proposed update to document on Post-Market Clinical Follow-Up Studies
Closed on 11 December 2020
Proposed enhancements to adverse event reporting for medical devices
Closed on 2 December 2020
Exploring options for the introduction of an Australian Unique Device Identification (UDI) System
Closed on 2 December 2020